Intellia Therapeutics
Jacqueline Growe is a Senior Scientist in Preclinical Genomics at Intellia Therapeutics, Inc., where responsibilities include executing genotoxicity data packages for regulatory filings and clinical programs, optimizing genomic assays, and managing a team. Previous experience includes roles as Genomics Scientist I at Ensoma, focusing on Vector Copy Number analysis and NGS library preparation, and Scientist I at Celsius Therapeutics, managing library construction and single-cell sequencing analysis. Earlier positions at Intellia include Senior Associate Scientist and Associate Scientist, where Jacqueline developed high-throughput CRISPR-Cas9 workflows and characterized genome editing. Jacqueline holds a Master’s degree in Biotechnology from the University of Pennsylvania and a Bachelor’s degree in Biology from Drexel University.
Intellia Therapeutics
9 followers
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.